InsidersTradesSigma
Track the ゼリア新薬工業株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, ゼリア新薬工業株式会社 has published 5 reports. Market capitalisation: €92.1bn. The latest transaction was reported on 29 July 2024 (Holding update). Among the most active insiders: Mitsubishi UFJ Financial Group Inc.. The full history is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,315 of 29,063 companies
72.5
score / 100
Value80
Quality65
FCF yld7.6%
Earn yld9.1%
EV/EBITDA6.9x
ROE8.4%
Gross mgn73%
Net mgn9.5%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 July 2024
Declarations5 total
ShareXTKSEDINET:S100U3FU
100.0% of flowShareXTKSEDINET:S100T8HR
0.0049% mcap61.6% of flowShareXTKSEDINET:S100O7UL
1,532,800 shares0.0031% mcap38.4% of flowShareXTKSEDINET:S100MDSY
5 of 5 declarations
Acerca de ゼリア新薬工業株式会社
Zeria Pharmaceutical Co., Ltd. es una empresa japonesa especializada en el sector de la salud y farmacéutico. Se centra en la investigación, el desarrollo y la comercialización de medicamentos innovadores.